Medical Distributors Industry's Performance Soars by +6.34% in a Week: $EDAP, $MCK, $ZYXI in Focus
The Medical Distributors industry has been making headlines recently with a significant increase in its performance, demonstrating a notable +6.34% growth over the past week. This sector plays a crucial role in the healthcare ecosystem, providing services such as pharmaceutical product distribution, medical device distribution, and biopharmaceutical product distribution. Some well-known players in this industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc., and Patterson Companies, Inc.
Group of Tickers in Focus
Let's delve deeper into the performance of some key tickers within the Medical Distributors industry:
- ABC (AmerisourceBergen Corporation)
- EDAP (No specific information available)
- CAH (Cardinal Health, Inc.)
- MCK (McKesson Corporation)
- COR (No specific information available)
- HSIC (No specific information available)
- OMI (Owens & Minor)
- PDCO (Patterson Companies, Inc.)
- AHG (Akso Health Group ADS)
- ZYXI (No specific information available)
Current Market Sentiment
However, it's important to note that despite recent positive growth, stocks within the Medical Distributors industry currently exhibit a Negative Outlook, as indicated by the 15 Indicator Stock Fear & Greed Index. Tickeron, a leading financial analysis platform, predicts a further decline of over 4.00% within the next month for this group, with a likelihood of 46%.
Over the past month, the daily ratio of advancing to declining volumes was 1.02 to 1, indicating a somewhat balanced market sentiment.
Interestingly, 10 stocks in this group of tickers have confirmed this negative outlook, with average odds of 66% based on the Declines indicator.
Market Capitalization
The Medical Distributors industry boasts an average market capitalization of approximately 10.1 billion USD. Among the tickers in focus, market caps vary significantly, ranging from 494.4K USD to a substantial 55.6 billion USD. Notably, MCK (McKesson Corporation) holds the highest valuation in this group at 55.6 billion USD, while the lowest valued company is SNYR at 494.4K USD.
High and Low Price Movements
Examining price movements within the Medical Distributors industry, we find that the average weekly price growth across all stocks was 2.96%. Looking at longer periods, the average monthly price growth was 2.63%, and the average quarterly price growth stood at 2.79%. AHG (Akso Health Group ADS) experienced the highest price growth at an impressive 76.97%, while PDCO (Patterson Companies, Inc.) experienced the most significant fall at -10.14%.
Recent notable price changes within this industry include:
- Owens & Minor (OMI), which was a top loser this week, declining -14.46%.
- Cardinal Health (CAH), which also saw a decline of -6.44%.
- Akso Health Group ADS (AHG), a top weekly loser for penny stocks, falling dramatically by -17.57%.
Volume Movements
In terms of trading volume, the Medical Distributors industry witnessed some noteworthy changes. The average weekly volume growth across all stocks was -10.79%. On a monthly scale, the average volume growth was -24.5%, and for the quarter, it averaged at -13.4%.
Notable volume events included:
- Akso Health Group ADS stock, which experienced a remarkable increase in volume for three consecutive days, resulting in a record-breaking daily growth of 543% of the 65-Day Volume Moving Average.
- Similarly, Akso Health Group ADS stock saw its volume surge for two consecutive days, with a daily growth of 581% of the 65-Day Volume Moving Average.
- On another occasion, Akso Health Group ADS stock recorded a one-day volume spike, with a daily growth of 952% of the 65-Day Volume Moving Average.
Individual Stock Insights
-
EDAP appears to be in a -3.22% downward trend, falling for three consecutive days on September 01, 2023. Such prolonged declines often indicate bearish sentiment, with odds of a continued downward trend at 79%.
-
MCK has seen its 10-day RSI Indicator leave the overbought zone on August 14, 2023, potentially signaling a shift from an upward to a downward trend. This development puts the odds of a downward move at 62%.
-
ZYXI recently had its Momentum Indicator turn negative on September 01, 2023, suggesting a new downward trend. The odds of a decline are estimated at 81%.
Summary
The Medical Distributors industry has recently shown positive growth, but a negative outlook looms large, with indications of a potential downturn in the near future. It's essential for investors to closely monitor individual stocks within this industry, as some are already displaying signs of bearish trends. The market's current sentiment and the performance of key tickers suggest that caution may be warranted in the coming weeks.
CAH in upward trend: 10-day moving average moved above 50-day moving average on June 10, 2026
The 10-day moving average for CAH crossed bullishly above the 50-day moving average on June 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on June 04, 2026. You may want to consider a long position or call options on CAH as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CAH just turned positive on May 15, 2026. Looking at past instances where CAH's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
CAH moved above its 50-day moving average on June 05, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CAH advanced for three days, in of 383 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 294 cases where CAH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for CAH moved out of overbought territory on June 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CAH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CAH broke above its upper Bollinger Band on June 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. CAH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (19.706). P/E Ratio (33.858) is within average values for comparable stocks, (42.409). Projected Growth (PEG Ratio) (1.373) is also within normal values, averaging (1.293). Dividend Yield (0.009) settles around the average of (0.007) among similar stocks. P/S Ratio (0.211) is also within normal values, averaging (5.990).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a maker of pharmaceuticals, medical, surgical and laboratory supplies as well as develops drug delivery systems
Industry MedicalDistributors
Advertisement